# Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts

> **NCT01532102** · PHASE1,PHASE2 · COMPLETED · sponsor: **Anaconda Pharma** · enrollment: 24 (actual)

## Conditions studied

- Anogenital Warts
- Condylomata Acuminata
- Human Papillomavirus Infection

## Interventions

- **DRUG:** AP611074
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01532102
- **Lead sponsor:** Anaconda Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-28
- **Primary completion:** 2013-05-06
- **Final completion:** 2013-05-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01532102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01532102, "Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01532102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*